SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)
ID: PAR-24-263 • Type: Posted
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 8/16/24 the National Institutes of Health posted grant opportunity PAR-24-263 for SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional).
The grant will be issued under grant program 93.172 Human Genome Research.
Timing
Posted Date
Aug. 16, 2024, 12:00 a.m. EDT
Closing Date
Dec. 2, 2024, 12:00 a.m. EST Due in 82 Days
Last Updated
Aug. 16, 2024, 2:46 p.m. EDT
Version
1
Archive Date
Jan. 7, 2025
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Award Sizing
Ceiling
$400,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-24-263.html
Additional Information Site